Founded by oncologists driven by a shared vision to make a global impact, our mission is to advance science-driven cancer research through collaboration between industry and academia. By leveraging the strengths and expertise of both sectors, we strive to deliver answers to crucial clinical questions.
We believe in physician-initiated and academia-industry collaborative trials as cornerstones of medical innovation to improve the chance of cure and the quality of life of our patients. Furthermore, we place great importance on intelligent cross-sector networking, which we see as the driving force for fostering research collaborations and accomplishing ambitious objectives that might otherwise be challenging to achieve.
Alongside our partners, we want to shape the future of cancer therapy, answer crucial clinical questions, and pose new ones, aiming for a world where a cancer diagnosis has lost its terror.
Approximately 25 years ago, the IKF was founded within the oncology focused hospital Krankenhaus Nordwest in Frankfurt, making it one of the first research institutes to recognize the importance of physician-initiated clinical cancer research and its special needs and requirements.
By providing professional structures, the IKF opened up opportunities for pharma-independent research projects, despite limited financial means, to develop innovative therapy options. This was made possible particularly through a strong patient orientation, the establishment of suitable platforms, and extensive networking within the scientific community. Research by the IKF fundamentally changed the treatment of stomach and esophageal cancer. The successful concept of the IKF from study idea to publication, and the trustful collaboration with cooperating scientists, was subsequently applied in many other tumor entities and has significantly influenced their treatment algorithms. Thus, clinical research physicians, together with the IKF as a partner, have been shaping the clinical research landscape at both national and international levels for years, changing treatment guidelines with the aim of improving chances of healing and patients' quality of life.